Parmax Pharma Share Price

BSE
PARMAX •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Parmax Pharma Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
89.62% Gain from 52W Low
33.6
TTM PE Ratio
Negative PE TTM
-5
Price to Book Ratio
High in industry
163.3
Dividend yield 1yr %
0
TTM PEG Ratio
0

Parmax Pharma Ltd shareholding Pattern

Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%

Parmax Pharma Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
8
Bearish Moving Averages
8
5Day EMA
48.30
10Day EMA
48.00
12Day EMA
47.80
20Day EMA
46.90
26Day EMA
46.20
50Day EMA
44.00
100Day EMA
40.70
200Day EMA
37.40
5Day SMA
48.30
10Day SMA
48.20
20Day SMA
47.00
30Day SMA
44.70
50Day SMA
44.40
100Day SMA
39.70
150Day SMA
36.60
200Day SMA
35.30
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
1052 Rs
1052 Rs
Week Rs
1137 Rs
1137 Rs
Month Rs
1111 Rs
1111 Rs
Resistance & Support
48.75
Pivot
Resistance
First Resistance
49.26
Second Resistance
50.26
Third Resistance
50.77
Support
First Support
47.75
Second support
47.24
Third Support
46.24
Relative Strength Index
59.46
Money Flow Index
80.37
MACD
1.55
MACD Signal
1.60
Average True Range
2.10
Average Directional Index
18.79
Rate of Change (21)
12.37
Rate of Change (125)
53.17

Parmax Pharma Ltd Company background

Founded in: 1994
Managing director: Umang Alkesh Gosalia
Incorporated in Nov.94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmaxs pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994 the Company had set up a plant to manufacture and market bulk drugs like amoxycillin trihydrate, ampicillin trihydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May97.
Read More

Parmax Pharma Ltd FAQs

You can easily buy Parmax Pharma Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -